A new blood test designed at Massachusetts General Hospital appears to accurately indicate whether a person is suffering from depression, according to a paper published in Molecular Psychiatry.

Researchers from Harvard Medical School and Brigham and Women’s Hospital found that exposure to high levels of iodide—widely given intravenously to patients for medical imaging procedures—is associated with an increased risk of thyroid disease.

A sizeable minority of patients diagnosed with lung and colorectal cancer continued smoking after their diagnosis, according to a recent Harvard Medical School study published in the journal Cancer.

Since the center's inception over ten years ago, Zeitels has used laser microsurgery to repair the vocal abilities of over a thousand patients with laryngeal tumors. In November, Dr. Zeitels operated on the Grammy Award-winning singer, Adele, who was suffering from recurrent bleeding of a benign polyp.

Second-year Harvard Medical School student David A. Obert was at an Oilers hockey game with his father last month in his hometown of Edmonton, Alberta, when he got the call.

Harvard Medical School Professor Donald M. Berwick ’68, a controversial figure in the health care policy field, announced last week that he will step down from his position as chief administrator of the Centers for Medicare and Medicaid Services at the end of this week.

After a long bout with lymphoma, Paul R. Epstein, instructor in medicine and associate director of the Center for Health and the Global Environment at the Harvard Medical School, died at the age of 67 at his home in Boston on Sunday.

Even when given free medicine, heart attack survivors are unlikely to consistently take the medications prescribed to prevent further disease and save lives, according to a new study led by Harvard Medical School researchers.

The scientists, using DNA sequencing technology, were able to retrace the evolution of specific bacteria and identify 17 adaptive genes that increase bacterial survival.

Research published earlier this week in the New England Journal of Medicine presents data showing that the anti-clotting drug rivaroxaban may change the future of post-heart attack treatment.